Searched for
ANTI ACNE DRUG
How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Weight-loss drugs are trending for rapid results, but new study reveals an unexpected benefit; with a catchA recent study published in JAMA Dermatology suggests that GLP-1 medications like Ozempic and Wegovy, commonly used for weight loss and dia...
- NMC lists therapeutic categories of drugs which can be sold sans prescriptionIn its 'Regulations relating to Professional Conduct of Registered Medical Practitioners" issued on August 2, the NMC stated that over-the-...
- Eris Lifesciences acquires 9 dermatology brands from Dr Reddy's for Rs 275 crThe transaction will be financed through borrowings and will achieve financial closure in the next few days, the drug firm said. In a separ...
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
- Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
- Sun Pharma might finally have a prescription for the specialty dreamThe ramp-up in its specialty business over the past year has increasingly turned skeptics into believers. The company has four major produc...
- Most analysts raise target prices on Sun Pharma after strong Q2CLSA, which raised the target price on Sun Pharma the most, said the drug maker's results were above estimates with key geographies perform...
- Brokerages up price targets on rising Sun, some point to cloudsMotilal Oswal has raised target price to Rs 900 and maintained a ‘buy’ rating on the back of improving traction in specialty products. Edel...
- Hair and skincare are passé: New-age men opt for 'brotox' to get rid of unpleasant frown linesIndian men spend almost the same amount of time as women in researching grooming products.
- Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash dealThe acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...
- Fairness creams can be risky for your skinIndiscriminate use of creams containing steroid combinations causes side effects, warn dermatologists who want to curb over-the-counter acc...
- Sun-Ranbaxy $4 billion deal: US anti-trust regulator FTC passes final orderFTC has passed its final order settling charges that Sun Pharma's $4 billion deal to acquire Ranbaxy Laboratories could result in unfair bu...
- Ranbaxy launches anti-acne drug in the US marketAccording to an analyst, the launch of Absorica would greatly benefit Ranbaxy as there are only 2-3 players currently selling the product i...
- Ranbaxy receives USFDA approval for anti acne drug AbsoricaRanbaxy laboratories has received an approval for an anti acne drug Absorica developed by US firm Cipher, the company said in a release to ...
- Ranbaxy recalls drug in USRanbaxy Laboratories is voluntarily recalling a batch of its best-selling anti-acne drug remaining in the US market that was banned earlier...
- Dr Reddy's in skin-care product distribution pact with US firmDr Reddy's Laboratories on Thursday said it has entered into an agreement with US-based dermatology and aesthetic medicine company Cosmeder...
- Ozone Ayurvedics launches anti acne productOzone Ayurvedics, a producer of herbal health and beauty care products, on Tuesday announced the launch an anti-acne product, targeting a t...
- Local pharma eyes layers of US skincare marketThe skincare segment in the US has caught the fancy of Indian drug makers who are looking at the inorganic route to consolidate their prese...
Load More
